24/7 Market News Lunch Break 8 Jan 2024
DENVER, Colo., Jan. 8, 2024 (247marketnews.com)- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aclarion Inc (NASDAQ:ACON), Spectaire Holdings Inc (NASDAQ:SPEC), Cellectar Biosciences Inc (NASDAQ:CLRB), Ardelyx (NASDAQ:ARDX), BioCryst Pharma (NASDAQ:BCRX)and Sidus Space (NASDAQ:SIDU).
News
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan- Aclarion (NASDAQ:ACON) is trading at $3.9301, up $0.8701 (+28.43%), on 23.2M shares traded.
Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia- Cellectar Biosciences (NASDAQ:CLRB) is trading at $3.40, up $0.69 (+25.46%), on 26.3M shares traded.
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities- Ardelyx (NASDAQ:ARDX) is trading at $7.75, up $1.59 (+25.81%), on 12.2M shares traded.
BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability- BioCryst Pharma (NASDAQ:BCRX) is trading at $7.55, up $1.47 (+24.06%), on 5.6M shares traded.
Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3- Butterfly Network (NYSE:BFLY) is trading at $1.23, up $0.22 (+21.78%), on 3.4M shares traded.
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024- Shattuck Labs (NASDAQ:STTK) is trading at $9.65, up $1.39 (+16.76%), on 395K shares traded.
FDA Grants Soligenix “Fast Track” Designation for Dusquetide in the Treatment of Oral Lesions of Behçet’s Disease- Cardio Diagnostics Holdings (NASDAQ:CDIO) is trading at $2.66, up $0.36 (+15.65%), on 1.9M shares traded.
This morning’s momentum movers include;
Spectaire Holdings (NASDAQ:SPEC) is trading at $2.46, up $0.77 (+45.56%), on 34.6M shares traded.
Sidus Space (NASDAQ:SIDU) is trading at $15.5355, up $2.4955 (+19.14%), on 1.3M shares traded.
NexImmune (NASDAQ:NEXI) is trading at $7.68, up $1.50 (+24.27%), on 4.2M shares traded.
Mersana Therapeutics (NASDAQ:MRSN) is trading at $2.63, up $0.36 (+16.08%), on 2.3M shares traded.
ATAI Life Sciences (NASDAQ:ATAI) is trading at $1.88, up $0.24 (+14.85%), on 1.7M shares traded.
Wolverine World Wide (NYSE:WWW) is trading at $9.07, up $1.34 (+17.40%), on 697K shares traded.
CONTACT:
24/7 Market News
24/7 MARKET NEWS, INC Disclaimer
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses.
Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.
Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.
Connect with 24/7 Market News:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.